Asthma is considered to be a serious public health problem worldwide.

Wondering if this dangerous heritage might extend even farther down the family line, Virender K. Rehan and his colleagues at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) exposed pregnant rats to nicotine. They then tested an additional generation—the mothers' great-grand-rats—for signs of asthma. Their results suggest that this group of rats is also at an increased risk of this condition, bearing the brunt of nicotine exposure three generations in the past.
The article is entitled "Perinatal Nicotine-Induced Transgenerational Asthma." It appears in the Articles in PresS section of the American Journal of Physiology-Lung Cellular and Molecular Physiology, published by the American Physiological Society. It is available online at http://bit.ly/19fcw03.
Methodology
The researchers separated pregnant rats into two groups. One group received a dose of nicotine injected under their skin daily—a model for smoking in humans—starting when they were 6 days pregnant until 21 days after they gave birth. Their pups were allowed to breastfeed as much as they wanted until they weaned at 3 weeks old. Another group of pregnant rats received only a placebo injected under their skin for the same time period. The researchers used rat pups from these pregnancies to breed subsequent generations of rats. When they reached the third generation born from the original rat moms—their great-grandchildren—they performed a series of tests on these animals to look for signs of asthma. They exposed these animals to a lung irritant to see how much it narrowed their airways, a test similar to one used to diagnose asthma in people. They also tested how the animals' windpipes responded to a chemical that caused them to contract, another indicator of asthma. No rats except for the pregnant moms were ever directly exposed to nicotine.
Results
Advertisements
Importance of the Findings
Advertisements
Study Team
In addition to Virender K. Rehan, the study team also includes Jie Liu, Reiko Sakurai and John S. Torday, all of LA BioMed. The study was supported in parts by grants from the NIH.
Source-Eurekalert